Sign in
4

Changes in Ownership

Stoke Therapeutics, Inc. Filed Acc 0001415889-25-019002

Director acquired 1,210 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
LEVIN ARTHUR A Director 2025-06-30 Option exercise +1,210 2,420 D
Derivatives
LEVIN ARTHUR A Director 2025-06-30 Option exercise · Restricted Stock Units −1,210 2,422 D
Loading xslF345X05/form4-07022025_080722.xml…